Request Appointment
428 E 72nd StOfc 400New York, NY 10021
Fax+1 212-746-8296
Overview of Dr. Sarva
Dr. Harini Sarva is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and Long Island Jewish Medical Center. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 22 years. She is one of 522 doctors at New York-Presbyterian Hospital and one of 140 doctors at Long Island Jewish Medical Center who specialize in Neurology. She has more than 70 publications and over 500 citings.
Education & Training
SUNY Downstate Health Sciences UniversityResidency, Neurology, 2008 - 2012
State University of New York Downstate Medical Center College of MedicineClass of 2004
Certifications & Licensure
NY State Medical License 2011 - 2028
NJ State Medical License 2020 - 2023
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants Start of enrollment: 2022 Oct 05
Roles: Principal Investigator
Publications & Presentations
PubMed
- Essential genetic testing in movement disorders - results from a Delphi study.Vanessa Carvalho, Leonor Correia Guedes, Emilia Gatto, Mayela Rodriguez-Violante, Christine Klein
Parkinsonism & Related Disorders. 2026-07-01 - Safety and efficacy of staged, bilateral magnetic resonance-guided focused ultrasound pallidothalamic tractotomy for motor complications of Parkinson's disease: a pros...Arif Dalvi, Howard M Eisenberg, Peihan Wu, Lloyd Zucker, Wei Chieh Chang
The Lancet. Neurology. 2026-07-01 - AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical Trial.Ronald G Crystal, Jonathan W Weinsaft, Stephen M Kaminsky, Anthony Caragiulo, Niamh Savage
JAMA Cardiology. 2026-06-17
Press Mentions
Stem Cell Therapy Shows Promise for Treating Advanced Parkinson's DiseaseApril 15th, 2025- Mitsubishi Tanabe Pharma America to Highlight Latest Advances in Neurodegenerative Research at the American Academy of Neurology 2025 Annual MeetingApril 3rd, 2025
- BlueRock Therapeutics to Incorporate Wearable and Invisible Contactless Digital Health Technologies from Rune Labs and Emerald Innovations in Parkinson’s Disease Clinical TrialMarch 14th, 2023
Grant Support
- Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)COLUMBIA UNIVERSITY HEALTH SCIENCES2018–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
